We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

54 hedge funds and large institutions have $15.3M invested in NanoViricides in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 8

39% more call options, than puts

Call options by funds: $97K | Put options by funds: $70K

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

2% more funds holding

Funds holding: 53 → 54 (+1)

0% more ownership

Funds ownership: 0.48% → 0.48% (+0%)

8% less capital invested

Capital invested by funds: $16.7M → $15.3M (-$1.32M)

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
22
Reduced
8
Closed
6
Calls
$97K
Puts
$70K
Net Calls
+$27K
Net Calls Change
-$402K

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$770K
2
VKH
Virtu KCG Holdings
New York
+$601K
3
BCM
Bridgeway Capital Management
Texas
+$180K
4
State Street
State Street
Massachusetts
+$126K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$97.6K

Top Sellers

1
CG
Colony Group
Massachusetts
-$1.3M
2
Goldman Sachs
Goldman Sachs
New York
-$141K
3
WAM
Weatherly Asset Management
California
-$128K
4
AQR Capital Management
AQR Capital Management
Connecticut
-$111K
5
TRCT
Tower Research Capital (TRC)
New York
-$67.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$80K +$3.18K +48 +3%
FWCM
27
Ferguson Wellman Capital Management
Oregon
$78K – – –
RG
28
Rathbones Group
United Kingdom
$77K – – –
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$73K +$89.4K +1,350 New
AIG
30
American International Group
New York
$72K -$3.18K -48 -3%
Renaissance Technologies
31
Renaissance Technologies
New York
$50K +$61.2K +924 New
SIA
32
Stancorp Investment Advisers
Oregon
$49K +$59.6K +900 New
RCM
33
RNC Capital Management
California
$47K – – –
BA
34
BlackRock Advisors
Delaware
$46K – – –
Bank of America
35
Bank of America
North Carolina
$33K +$26.1K +395 +184%
Wells Fargo
36
Wells Fargo
California
$22K +$3.38K +51 +14%
Citigroup
37
Citigroup
New York
$20K +$18.9K +285 +343%
SSB
38
Sandy Spring Bank
Maryland
$17K +$10.3K +155 +93%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$17K +$16.5K +250 +481%
NSIM
40
North Star Investment Management
Illinois
$16K – – –
Simplex Trading
41
Simplex Trading
Illinois
$12K +$14.7K +222 New
Group One Trading
42
Group One Trading
Illinois
$10K +$12.5K +189 New
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$9K +$1.79K +27 +19%
AllianceBernstein
44
AllianceBernstein
Tennessee
$8K – – –
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$8K – – –
RC
46
RegentAtlantic Capital
New Jersey
$7.77K +$9.47K +143 New
Creative Planning
47
Creative Planning
Kansas
$6K – – –
TRCT
48
Tower Research Capital (TRC)
New York
$5K -$67.5K -1,020 -92%
DADC
49
D.A. Davidson & Co
Montana
$5K – – –
Barclays
50
Barclays
United Kingdom
$5K +$2.18K +33 +37%
1
2
3

NNVC Hedge Fund Activity: Q4 2014 in Review

54 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2014, worth a combined $15.3M — down 8% from $16.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NNVC positions and 6 closed out — a net gain of 2 holders — while 22 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $770K. The largest seller was Colony Group, exiting entirely with an estimated $1.3M sold.

  • 54 institutional investors held NanoViricides (NNVC) as of Q4 2014, up from 53 in Q3 2014.
  • Funds reported $15.3M of NanoViricides stock for Q4 2014, down 8% quarter-over-quarter.
  • 8 funds opened new NanoViricides positions in Q4 2014 and 6 closed out, a net change of +2 holders.
  • The largest NanoViricides buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $770K added.
  • The largest NanoViricides seller in Q4 2014 was Colony Group, an estimated $1.3M sold.

Based on aggregated 13F filings for Q4 2014.